Cigna Corporation (CI)
NYSE · Healthcare · Medical - Healthcare Plans
Profile
Cigna Corporation
- Exchange
- NYSE
- Ticker
- CI
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Country
- US
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
Key facts
Cigna Corporation: key facts
- Cigna Corporation (NYSE: CI) is a Medical - Healthcare Plans company in the Healthcare sector.
- In fiscal 2025, Cigna Corporation reported revenue of $275.0B and net income of $6.0B.
- Revenue grew 12.1% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $286.3B and net income was $6.0B.
MonkScore
Cigna Corporation's MonkScore
MonkScore
MonkScore range: 30–39
as of November 2026
Sector rank: 431 of 638 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth70–79
- Profitability60–69
- Quality50–59
- Market Conviction10–19
- Safety10–19
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–9 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Cigna Corporation's annual figures and the last twelve months, in USD. Last report: 30 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $286.3B | $275.0B | $247.1B | $195.3B | $180.5B | $174.1B |
| Gross profit | $29.4B | $26.0B | $26.0B | $25.2B | $23.5B | $23.0B |
| Operating income | $9.6B | $9.1B | $9.4B | $8.5B | $8.5B | $7.9B |
| Net income | $6.0B | $6.0B | $3.4B | $5.2B | $6.7B | $5.4B |
| Operating cash flow | $9.4B | $9.6B | $10.4B | $11.8B | $8.7B | $7.2B |
| Capital expenditure | -$1.2B | -$1.2B | -$1.4B | -$1.6B | -$1.3B | -$1.2B |
| Free cash flow | $8.3B | $8.4B | $9.0B | $10.2B | $7.4B | $6.0B |
| Total debt | $31.1B | $31.5B | $32.0B | $30.9B | $31.6B | $34.3B |
| Cash | $6.2B | $7.7B | $7.6B | $7.8B | $5.9B | $5.1B |
Revenue growth a year
- 1-year
- 11.3%
- 3-year
- 15.1%
- 4-year
- 12.1%
Compound growth between fiscal years.
Peers
Similar companies
- Elevance Health Inc.NYSE:ELVMonkScore range: 30–39
- Centene Corp.NYSE:CNCMonkScore range: 40–49
- Alignment Healthcare, Inc.NASDAQ:ALHCMonkScore range: 40–49
- Molina Healthcare, Inc.NYSE:MOHMonkScore range: 50–59
- CVS Health Corp.NYSE:CVSMonkScore range: 50–59
- Humana Inc.NYSE:HUMMonkScore range: 60–69
- UnitedHealth Group IncorporatedNYSE:UNHMonkScore range: 60–69
- Clover Health Investments, Corp.NASDAQ:CLOVMonkScore range: 80–89
Compare
Compare with
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 14 November 2026.